Results

Total Results: 579 records

Showing results for "Grade D Cancer".

  1. MEDLINE Searches (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
    March 01, 2009 - $ or tumor$ or malignan$ or carcino$ or neoplas$)).mp. … /ep, et 8 4 and 7 9 exp Breast Neoplasms/pc, eh 10 exp Breast Neoplasms/ge   A1-6 11 4 and … in situ: data from the Connecticut Tumor Registry. … Re: second cancers after adjuvant tamoxifen therapy for breast cancer. … EPC GRADE Criteria for Assigning Strength of Evidence* Grade Definition High High confidence that
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
    January 01, 2015 - pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignancies … Hahn D, Cody June D, Hodson Elisabeth M. … Horey D, Kealy M, Davey M-A, et al. … Kumar P, Chawla D, Deorari A. … Trastuzumab containing regimens for early breast cancer.
  3. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
    December 01, 2009 - Layout 1 Background Breast cancer is the second most common malignancy of women, with over 180,000 … However, it is generally acknowledged that early diagnosis and treatment of breast tumors leads to improved … The grade was developed after consideration of the quality of the evidence base, the size of the evidence … Summary of key accuracy findings (Key Question 1) Number of Number of Number of malignancies invasive … missed Risk of expected per cancers cancers malignancy 1,000 biopsy expected per Strength of expected
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer_research-protocol.pdf
    July 24, 2013 - d. … d. … d. … Liver Neoplasms/ 3. ("hepatocellular cancer" or "hepatocellular carcinoma" or "HCC").ti,ab. 4. … D.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-grading_methods.pdf
    July 01, 2012 - with a BI-RADS® 4 score following mammography and expected to have an approximate prebiopsy risk of malignancy … Owens DK, Lohr KN, Atkins D, et al. … Atkins D, Fink K, Slutsky J. … Samson D, Schoelles KM. … Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes.
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/evidence-examples_white-paper.pdf
    April 01, 2014 - In childhood cancer survivors, a linear dose-response relationship was observed between primary neoplasms … Norris S, Atkins D, Bruening W, et al. … Chou R, Aronson N, Atkins D, et al. … Norris SL, Moher D, Reeves BC, et al. … New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
    December 16, 2014 - grade of the tumor ES-3 “The key finding of the analysis was that the Prostate Cancer Intervention … may sometimes underestimate the true Gleason grade of the tumor.” … , Reduces the risk of a second malignant neoplasms (SMN) in prostate patients compared with contemporary … Keizman D, Zahurak M, Sinibaldi V, et al. … Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x- ray therapy for
  8. effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_disposition-comments.pdf
    February 24, 2016 - d. … The main point is that larger tumors are associated with malignancy, and that the OR of 1.3 gives a … What was the denominator for assessing the diagnostic accuracy of determining tumor grade. specifically … Then, among patients with surgical pathology available, we compared final tumor grade to biopsy grade … Please see Michael D.
  9. Hi Les, (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rtc-design-principles_research.pdf
    January 01, 2009 - and high-grade lesions detected, but one test might detect a higher proportion of high-grade cytological … tumor foci in women with a diagnosis of early breast cancer on mammography and ultrasonography planned … mastectomy provides the same relative effects for patients detected by either test, the number of tumor … needle biopsy to detect false positive MRI results, some women with a positive MRI finding of multiple tumor … Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
    September 13, 2013 - (incident or mortality)  Total cancer  Prostate cancer  Colorectal cancer  Breast cancer  … BMD, BMC25(OH)D; 1,25(OH)2D Calcium balance Bone health CVD Cancer Muscle function Cancer markers … cancer, and cancer-specific mortality … Several additional criteria will be considered in assigning a ROB grade. … If desired, we will grade the SOE, based on the AHRQ Methods Guide (chapter 1011).
  11. effectivehealthcare.ahrq.gov/products/vitamin-d-calcium/research-protocol
    June 10, 2013 - (incident or mortality) Total cancer Prostate cancer Colorectal cancer Breast cancer Pancreatic … People with previous cancer (or cancer survivors), previous fractures, and precancerous conditions (e.g … cancer, and cancer-specific mortality. … Several additional criteria will be considered in assigning a ROB grade. … If desired, we will grade the SOE, based on the AHRQ Methods Guide (chapter 10 11 ).
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
    February 01, 2018 - Chou R, Aronson N, Atkins D, et al. … Chou R, Aronson N, Atkins D, et al. … D-1 Appendix D. Key Informant Interview Themes 1. … D-2 • Sometimes consider composite safety AE. … for NIMI Bladder Cancer?
  13. effectivehealthcare.ahrq.gov/products/breast-biopsy-update/research-protocol
    September 20, 2013 - is the second most common malignancy (after skin cancer), and the second most common cause of cancerD. … Morrison A, Polisena J, Husereau D, et al. … Wells G, Shea B, O'Connell D, et al. … /di or exp breast neoplasms/di or exp breast disease/di or exp breast diseases/di 4   (breast or
  14. Moyer_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/moyer_eccs2012.pdf
    January 01, 2012 - Controversy “Those PSA  [prostate-­‐specific  antigen]  blood  tests  that check for prostate  cancer …  do more harm  than good and healthy men should no longer receive them  as part of routine cancer … Moderate B B C D Low Insufficient (I Statement) Slide 6: U.S. … Preventive Services  Task Force Recommendation Grades Grade Definition A The U.S. … D The USPSTF recommends against the service.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_executive.pdf
    February 01, 2012 - Adenoma—Benign tumor from epithelial tissue. … adenomas—Adenomas 1 cm or greater, or with villous components (tubulovillous or villous), or with high-grade … Stool DNA and occult blood testing for screen detection of colorectal neoplasia. … Detection of stool DNA mutations before and after treatment of colorectal neoplasia. … Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia
  16. effectivehealthcare.ahrq.gov/products/cystic-fibrosis-hgh/research-protocol
    January 22, 2010 - KQ 5: What is the risk of malignancy associated with rhGH use as determined by: (a) markers of cancerD. … Schnabel D, et al. … Hardin D. … Follman D, Elliot P, Suh I, Cutler J.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
    November 20, 2014 - well as on tumor size and extent, while for rectal cancer imaging of distant metastases is not as important … as is gauging tumor depth and local spread.” … Also “not statistically significant” should not be a reason for the grade to be “insufficient”. … For preoperative rectal cancer T (tumor) staging, ERUS is less likely than CT to incorrectly stage ( … d.
  18. effectivehealthcare.ahrq.gov/products/cancer-decision-support-tools/research-protocol
    November 12, 2013 - For example, choosing to remove or destroy a low-grade prostatic malignancy can lead to complications … D. … Saslow D, Solomon D, Lawson HW, et al. … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR precancerous OR hypertrophy … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR precancerous)) Filters:Publication
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-evidence_methods.pdf
    November 01, 2013 - Atkins D, Fink K, Slutsky J. … Owens DK, Lohr KN, Atkins D, et al. … Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. … the data published in observational studies of the association between diet and prostate or bladder cancer … Sterne JA, Gavaghan D, Egger M.
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
    August 22, 2008 - KQ 5: What is the risk of malignancy associated with rhGH use as determined by: a) markers of cancerD. … Schnabel D, Grasemann C, Stabb D, et al. … Hardin DS, Adams-Huet B, Brown D, et al. … FollmanN D, ElliotT P, Suh I, et al.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: